Free Access
Med Sci (Paris)
Volume 33, Number 5, Mai 2017
Page(s) 491 - 493
Section Nouvelles
Published online 14 June 2017
  1. FerrariA, Vincent-SalomonA, PivotX, et al. A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers. Nat Commun 2016 ; 7 : 12222. [PubMed] [Google Scholar]
  2. RomondEH, PerezEA, BryantJ, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005 ; 353 : 1673–1684. [Google Scholar]
  3. BeijeN, OnstenkW, KraanJ, et al. Prognostic impact of HER2 and ER status of circulating tumor cells in metastatic breast cancer patients with a HER2-negative primary tumor. Neoplasia 2016 ; 18 : 647–653. [PubMed] [Google Scholar]
  4. WallwienerM, HartkopfAD, RiethdorfS, et al. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients. BMC Cancer 2015 ; 15 : 403. [CrossRef] [PubMed] [Google Scholar]
  5. MengS, TripathyD, SheteS, et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A 2004 ; 101 : 9393–9398. [CrossRef] [PubMed] [Google Scholar]
  6. JordanNV, BardiaA, WittnerBS, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature 2016 ; 537 : 102–106. [CrossRef] [PubMed] [Google Scholar]
  7. Ozkumur E, Shah AM, Ciciliano JC, et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med 2013; 5 : 179ra47. [Google Scholar]
  8. HurtadoA, HolmesKA, GeistlingerTR, et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 2008 ; 456 : 663–666. [CrossRef] [PubMed] [Google Scholar]
  9. D’AngeloRC, OuzounovaM, DavisA, et al. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Mol Cancer Ther 2015 ; 14 : 779–787. [Google Scholar]
  10. Moyret-LalleC, PommierR, BouardC, et al. Plasticité des cellules cancéreuses et dissémination métastatique. Med Sci (Paris) 2016 ; 32 : 725–731. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  11. SchrammA, FriedlTW, SchochterF, et al. Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program. Arch Gynecol Obstet 2016 ; 293 : 271–281. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.